本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Lexeo Therapeutics

9.04
+0.05000.56%
盤後9.040.00000.00%17:32 EST
成交量:48.49萬
成交額:440.10萬
市值:6.60億
市盈率:-3.68
高:9.25
開:8.90
低:8.84
收:8.99
52周最高:10.38
52周最低:1.45
股本:7,298.73萬
流通股本:4,500.50萬
量比:0.33
換手率:1.08%
股息:- -
股息率:- -
每股收益(TTM):-2.4545
每股收益(LYR):-3.0934
淨資產收益率:-80.69%
總資產收益率:-44.66%
市淨率:5.46
市盈率(LYR):-2.92

資料載入中...

2025/11/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report
2025/10/17

重要事件披露

Form 8-K - Current report
2025/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/17

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/10/16

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/10/07

重要事件披露

Form 8-K - Current report
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/14

重要事件披露

Form 8-K - Current report
2025/06/30

重要事件披露

Form 8-K - Current report